The mechanism of Sanzi Yangqin decoction for asthma treatment based on network pharmacology and experimental verification

The mechanism of Sanzi Yangqin decoction for asthma treatment based on network pharmacology and experimental verification

Abstract Background Asthma is a chronic airway inflammatory disease characterized by airway inflammation, mucus hypersecretion, airway hyper-reactivity. Sanzi Yangqin Decoction (SZYQD) is widely prescribed for asthma treatment. Its anti-asthma activities have been reported in animal model, but the e...

Full description

Bibliographic Details
Main Authors: Yue Wu, Zhenhua Ni, Shiqiang Wang, Yipeng Sun, Xuming Luo, Xiongbiao Wang, Jinjin Liu
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Complementary Medicine and Therapies
Subjects:
SZYQD
Asthma
IL-6
AKT
Network pharmacology
Online Access:https://doi.org/10.1186/s12906-023-04272-6

Similar Items

Similar Items